investment bank logoinvestment bank logoinvestment bank logoinvestment bank logo
  • ADVISORY
    • BUY SIDE M&A
    • SELL SIDE M&A
    • CAPITAL RAISE
    • BUSINESS VALUATIONS
  • DEALS
  • ABOUT
  • CONTACT

Healthcare Analytics – Industry Performance

This article is one in a series covering investments, transactions and general trends in healthcare and healthcare analytics.

Current Performance & Industry Outlook

The global market for healthcare analytics reached $6.2 billion in 2016. This market should reach nearly $7.2 billion in 2017 and $14.9 billion by 2022, at a compound annual growth rate (CAGR) of 15.8% [i]. In North America, healthcare analytics spending is expected to total $7.2 billion by the end of the decade [ii].

Key External Drivers

Demand for Healthcare Analytics in the United States is primarily determined by the following factors:

  • Total healthcare expenditures
  • Maturing population ages 65 and above
  • Pressure to reduce healthcare costs
  • Federal healthcare mandates
  • The trend toward paperless work spaces

Total Healthcare Expenditures

Increases in total healthcare expenditures are directly correlated with increases in demand for healthcare analytics services. Research from the Centers for Medicare and Medicaid Services estimated healthcare spending to be 17.9% of total U.S. Gross Domestic Product in 2016, and projects spending to comprise 20.1% of U.S. GDP by 2025 [iii].

Maturing Population Demographics

As residents ages 65 and above represent an increasingly larger percentage of the population, the need for analytics services will increase considerably. With old age comes a high likelihood of chronic and infectious diseases; therefore, the need for descriptive, diagnostic, and prescriptive analytics will continue to be in high demand.

Pressure to Reduce Costs, Federal Healthcare Mandates & Digitization

To reduce costs and improve patient care, federal mandates such as the American Reinvestment & Recovery Act (ARRA) and the Health Information Technology for Economic and Clinical Health (HITECH) Act have provided incentives to increase collaboration between providers and government programs. The HITECH Act defines the implementation and meaningful use of Electronic Health Records (EHR) as a critical national goal. Ensuring the proper use of Electronic Health Records will help “reduce [record] disparities, control chronic diseases, and build a health promoting healthcare system that is accountable for the health of our communities and our country” [v].

Risk Factors

Factors which may restrict industry growth could be:

  • Lack of skilled labor with analytical skills
  • Change in public perception regarding patient data confidentiality and transparency
  • Increase in governmental regulation

Governmental Regulation

In 2016, the European Union passed a new law called the General Data Protection Regulation (GDPR) which imposes new requirements regarding the handling and privacy of personal data. The law will become effective in May 2018, and could result in hefty monetary penalties being levied against non-compliant firms. Firms that conduct business outside the United States could see an increase in the cost to provide certain products and services; additionally, the increased costs could limit the industry’s ability to provide certain products to the consumer.

Industry Life Cycle

The Healthcare Analytics industry is in the growth stage of its economic lifecycle; Revenue growth within the industry is notably higher than the growth rate of the overall economy. A very high degree of technological innovation characterizes the industry, with smaller firms having the potential to disrupt larger players by adapting quickly to fill market needs. Larger firms may opt to develop new solutions in-house or through acquisitions of smaller companies. As the United States population matures, demand for Healthcare Analytics will continue to expand. As services and product capabilities are enhanced, the industry will experience a self-reinforcing network effect: as more data collected and analyzed, the further costs will be reduced, which will increase demand, etc.

Sources

  1. Healthcare Analytics: Technologies and Global Markets, BCC Research (2017),
    https://www.bccresearch.com/market-research/healthcare/healthcare-analytics-technologies-markets-report-hlc187b.html/.
  2. North America Healthcare Analytics Market, Market Data Forecast (2016),
    https://www.marketdataforecast.com/market-reports/north-america-healthcare-analytics-market-48/.
  • National Health Expenditure Data, Centers for Medicare & Medicaid Services (2017), https://www.cms.gov/.
  1. Population Ages 65 and Above for the United States, FRED (2017), https://fred.stlouisfed.org/series/SPPOP65UPTOZSUSA/.
  2. Meaningful Use, Centers for Disease Control and Prevention,
    https://www.cdc.gov/ehrmeaningfuluse/introduction.html/.

Britton Sorensen contributed to this article.

  • Author
  • Recent Posts
Nate Nead
Nate Nead
Nate Nead is a licensed investment banker and Principal at Deal Capital Partners, LLC, a middle-marketing M&A and capital advisory firm. Nate works with corporate clients looking to acquire, sell, divest or raise growth capital from qualified buyers and institutional investors. He holds Series 79, 82 & 63 FINRA licenses and has facilitated numerous successful engagements across various verticals. Four Points Capital Partners, LLC a member of FINRA and SIPC. Nate resides in Seattle, Washington. Check the background of this Broker-Dealer and its registered investment professionals on FINRA's BrokerCheck.
Nate Nead
Latest posts by Nate Nead (see all)
  • Covid-19 Impact on US Private Capital Raising Activity in 2020 - May 27, 2021
  • Healthcare 2021: Trends, M&A & Valuations - May 19, 2021
  • 2021 Outlook on Media & Telecom M&A Transactions - May 12, 2021
Nate Nead
Nate Nead
Nate Nead is a licensed investment banker and Principal at Deal Capital Partners, LLC, a middle-marketing M&A and capital advisory firm. Nate works with corporate clients looking to acquire, sell, divest or raise growth capital from qualified buyers and institutional investors. He holds Series 79, 82 & 63 FINRA licenses and has facilitated numerous successful engagements across various verticals. Four Points Capital Partners, LLC a member of FINRA and SIPC. Nate resides in Seattle, Washington. Check the background of this investment professional on FINRA's BrokerCheck.

Related posts

May 27, 2021

Covid-19 Impact on US Private Capital Raising Activity in 2020


Read more
May 19, 2021

Healthcare 2021: Trends, M&A & Valuations


Read more
May 12, 2021

2021 Outlook on Media & Telecom M&A Transactions


Read more

Get in touch

[]
1
Step 1

keyboard_arrow_leftPrevious
Nextkeyboard_arrow_right


investment banking Logo

Services

  • M&A Advisory
  • Sell-Side M&A
  • Buy-Side M&A
  • Raise Capital

About

  • About Us
  • Our Deals
  • M&A Blog
  • Contact Us

© Copyright Deal Capital Partners, LLC.

Privacy Policy | Terms of Service | Listing Agreement

This does not constitute an offer to sell or a solicitation of an offer to buy any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of a final private placement offering memorandum and subscription agreement, and will be subject to the terms and conditions and risks delivered in such documents.

M&A advisory services offered through MergersandAcquisitions.net. Securities transactions are conducted through Four Points Capital Partners, LLC (4 Points), a member of FINRA and SIPC. Deal Capital Partners, LLC and 4 Points are not affiliated. Check the background of this Broker-Dealer and its registered investment professionals on FINRA's BrokerCheck.

An Invest.net Partner